505(b)(2) NDA or ANDA? (10of28) Generic Drugs Forum - Apr. 3-4, 2019

CDER Office of Generic Drugs’ Elizabeth Friedman and Office of New Drugs’ Beth Goldstein provide practical regulatory and scientific advice on selecting the appropriate abbreviated pathway for a proposed product.
Learn more at www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Visit www.fda.gov/cd... and www.fda.gov/cd... for news and a repository of training activities.
Email: [e-mail]
Phone: [phone] I [phone]
LinkedIn: / cder-small-business-an...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...